Venkat R. Thalladi

6 Patents

• US123515612025

  Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid and Uses Thereof

  Theravance Biopharma R&D IP, LLC

  0 cites
• US117951802023

  Formulation of a Pan-jak Inhibitor

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites
• US117808522023

  Methods for Treating Crohn's Disease Using 3-((1r,3s,5s)-3-((7-((5-methyl-1h-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

  Theravance Biopharma R&D IP, LLC

  0 cites
• US117185912023

  Crystalline (2s,4r)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- Methylpentanoic Acid and Uses Thereof

  Theravance Biopharma R&D IP, LLC

  0 cites
• US117186162023

  JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

  Theravance Biopharma R&D IP, LLC

  0 cites
• US116423322023

  (2r,4r)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic Acid

  THERAVANCE BIOPHARMA R&D IP, LLC

  0 cites